Difluoroketamide derivatives
US-10428108-B2 · Oct 1, 2019 · US
US11059858B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11059858-B2 |
| Application number | US-201816121244-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2018 |
| Priority date | Mar 4, 2016 |
| Publication date | Jul 13, 2021 |
| Grant date | Jul 13, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel compounds having the general formula (I)wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R23 are as described herein, compositions including the compounds and methods of using the compounds.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein: R 1 is selected from: i) C 1-6 -alkyl, ii) C 3-8 -cycloalkyl substituted with R 24 , R 25 and R 26 , iii) halo-C 1-6 -alkyl, iv) heterocycloalkyl-C 1-6 -alkyl substituted with R 24 , R 25 and R 26 , v) aryl-C 1-6 -alkyl substituted with R 24 , R 25 and R 26 , and vi) heteroaryl-C 1-6 -alkyl substituted with R 24 , R 25 and R 26 ; R 2 , R 3 , R 4 , R 6 , R 7 , R 9 , R 10 and R 23 are independently selected from: i) H, ii) C 1-6 -alkyl, and iii) C 3-8 -cycloalkyl; R 5 is selected from: i) aryl substituted with R 12 , R 13 and R 14 , ii) aryl-C 1-6 -alkyl substituted with R 12 , R 13 and R 14 , iii) heteroaryl substituted with R 12 , R 13 and R 14 , and iv) heteroaryl-C 1-6 -alkyl substituted with R 12 , R 13 and R 14 ; R 8 is selected from: i) H, ii) hydroxy, iii) amino-C 1-6 -alkyl substituted on the nitrogen atom by one or two substituents selected from H, C 1-6 -alkylcarbonyl, C 1-6 -alkoxycarbonyl, C 1-6 -alkyl, arylcarbonyl and heteroarylcarbonyl, wherein the arylcarbonyl and the heteroarylcarbonyl are substituted with R 15 , R 16 and R 17 , iv) aminocarbonyl substituted on the nitrogen atom by one or two substituents selected from H, C 1-6 -alkylcarbonyl, C 1-6 -alkoxycarbonyl, C 1-6 -alkyl, arylcarbonyl and heteroarylcarbonyl, wherein the arylcarbonyl and the heteroarylcarbonyl are substituted with R 15 , R 16 and R 17 , v) aminocarbonyl-C 1-6 -alkyl substituted on the nitrogen atom by one or two substituents selected from H, C 1-6 -alkylcarbonyl, C 1-6 -alkoxycarbonyl, C 1-6 -alkyl, arylcarbonyl and heteroarylcarbonyl, wherein the arylcarbonyl and the heteroarylcarbonyl are substituted with R 15 , R 16 and R 17 , vi) carboxy, vii) carboxy-C 1-6 -alkyl, viii) C 1-6 -alkoxy, ix) C 1-6 -haloalkoxy, x) C 1-6 -alkoxycarbonyl, xi) C 1-6 -alkoxycarbonyl-C 1-6 -alkyl, xii) C 3-8 -cycloalkyl, xiii) aryl substituted with R 15 , R 16 and R 17 , xiv) aryl-C 1-6 -alkyl substituted with R 15 , R 16 and R 17 , xv) aryl-C 1-6 -alkoxy substituted with R 15 , R 16 and R 17 , xvi) heteroaryl substituted with R 15 , R 16 and R 17 , xvii) heteroaryl-C 1-6 -alkyl substituted with R 15 , R 16 and R 17 , xviii) heteroaryl-C 1-6 -alkoxy substituted with R 15 , R 16 and R 17 , xix) heterocycloalkyl substituted with R 15 , R 16 and R 17 , xx) heterocycloalkyl-C 1-6 -alkyl substituted with R 15 , R 16 and R 17 , and xxi) heterocycloalkyl-C 1-6 -alkoxy substituted with R 15 , R 16 and R 17 ; R 11 is selected from: i) amino-C 1-6 -alkyl substituted on the nitrogen atom by R 21 and R 22 , ii) C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , iii) C 3-8 -cycloalkyl-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , iv) C 3-8 -cycloalkyl(halo)-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , v) aryl substituted with R 18 , R 19 and R 20 , vi) aryl-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , vii) aryl-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , viii) aryl-heterocycloalkyl substituted with R 18 , R 19 and R 20 , ix) aryl(halo)-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , x) aryl(halo)-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xi) aryl(halo)-heterocycloalkyl substituted with R 18 , R 19 and R 20 , xii) aryloxy-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , xiii) aryloxy-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xiv) aryloxy-heterocycloalkyl substituted with R 18 , R 19 and R 20 , xv) aryloxy(halo)-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xvi) aryloxy(halo)-heterocycloalkyl substituted with R 18 , R 19 and R 20 , xvii) aryloxy(halo)-C 1-6 -alkyl, xviii) heterocycloalkyl substituted with R 18 , R 19 and R 20 , xix) heterocycloalkyl-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , xx) heterocycloalkyl-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xxi) heterocycloalkyl(halo)-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xxii) heterocycloalkyl(halo)-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , xxiii) heteroaryl substituted with R 18 , R 19 and R 20 , xxiv) heteroaryl-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , xxv) heteroaryl-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xxvi) heteroaryl(halo)-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , xxvii) heteroaryl(halo)-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , xxviii) heteroaryloxy-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , xxix) heteroaryloxy-C 3-8 -cycloalkyl substituted with R 8 , R 19 and R 20 , xxx) heteroaryloxy(halo)-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , and xxxi) heteroaryloxy(halo)-C 1-6 -alkyl substituted with R 8 , R 19 and R 20 ; R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 24 , R 25 and R 26 are independently selected from: i) H, ii) cyano, iii) halogen, iv) oxo, v) C 1-6 -alkyl, vi) amino substituted on the nitrogen atom by two substituents independently selected from H, C 1-6 -alkyl, C 1-6 -alkoxycarbonyl, arylcarbonyl and heteroarylcarbonyl, vii) amino-C 1-6 -alkyl substituted on the nitrogen atom by two substituents independently selected from H, C 1-6 -alkyl, C 1-6 -alkoxycarbonyl, arylcarbonyl and heteroarylcarbonyl, viii) C 1-6 -alkyl, ix) halo-C 1-6 -alkyl, x) C 3-8 -cycloalkyl, xi) C 1-6 -alkoxycarbonyl-C 1-6 -alkyl, xii) carboxy-C 1-6 -alkyl, xiii) C 1-6 -alkoxycarbonyl-C 1-6 -alkylaminocarbonyl-C 1-6 -alkyl, xiv) carboxy-C 1-6 -alkylaminocarbonyl-C 1-6 alkyl, xv) C 1-6 -alkoxy, xvi) halo-C 1-6 -alkoxy, xvii) C 1-6 -alkoxycarbonyl-C 1-6 -alkoxy, xviii) carboxy-C 1-6 -alkoxy, xix) C 1-6 -alkoxycarbonyl-C 1-6 -alkylaminocarbonyl-C 1-6 -alkoxy, xx) carboxy-C 1-6 -alkylaminocarbonyl-C 1-6 -alkoxy, and xxi) heterocycloalkyl; and R 21 and R 22 are independently selected from: i) H, ii) C 1-6 -alkoxycarbonyl, iii) carboxy-C 1-6 -alkyl, iv) arylcarbonyl, and v) heteroarylcarbonyl. 2. The compound or a pharmaceutically acceptable salt thereof according to claim 1 , wherein: R 1 is halo-C 1-6 -alkyl; R 2 is selected from: i) C 1-6 -alkyl, and ii) C 3-8 -cycloalkyl; R 3 , R 4 , R 6 , R 7 , R 9 , R 10 and R 23 are H; R 5 is phenyl substituted with R 12 , R 13 and R 14 ; R 8 is selected from: i) H, ii) hydroxy, and iii) phenyl substituted with R 15 , R 16 and R 17 ; R 11 is selected from: i) amino-C 1-6 -alkyl substituted on the nitrogen atom by R 21 and R 22 , ii) phenyl substituted with R 18 , R 19 and R 20 , iii) phenyl-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , iv) phenyl-C 3-8 -cycloalkyl substituted with R 18 , R 19 and R 20 , v) phenyl(halo)-C 1-6 -alkyl substituted with R 18 , R 19 and R 20 , and vi) heteroaryl substituted with R 18 , R 19 and R 20 , wherein the he
with the first amino acid being basic · CPC title
containing heteroatoms different from O, S, or N · CPC title
the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala · CPC title
the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr · CPC title
and aromatic or cycloaliphatic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.